IP Library Granted Patent US 10,632,237
Granted Patent B2
US 10,632,237 · App. 15/229,392 · Granted Apr 28, 2020

Tangential flow filter system for the filtration of materials from biologic fluids

Inventors: Emily Rolfes Meyering (St. Louis Park, MN); Gary Seim (Minneapolis, MN); Abhi Vase (Los Altos Hills, CA); Ben Krehbiel (Lake City, MN); Blake Hedstrom (Minneapolis, MN); Aaron McCabe (Edina, MN); Jack Mondry (Edina, MN)
Assignee: MINNETRONIX, INC.
A61M1/0098B01D61/145B01D61/147A61M27/006A61M2202/0464A61M2205/3327A61M2205/3334A61M2205/75A61M2230/005B01D2313/12B01D2313/18B01D2315/08B01D2315/10B01D2317/022B01D2317/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,632,237
App. No.
15/229,392
Granted
Apr 28, 2020
Kind
B2
Abstract

Systems and methods for filtering materials from biologic fluids are discussed. Embodiments may be used to filter cerebrospinal fluid (CSF) from a human or animal subject. In an example, CSF is separated into a permeate and retentate using a tangential flow filter. The retentate is filtered again and then returned to the subject with the permeate. During operation of the system, various parameters may be modified, such as flow rate and waste rate.

Claims (56)

1. A method for filtering materials from cerebrospinal fluid (CSF) of a human or animal subject, the method comprising:

withdrawing a volume of fluid comprising CSF from a CSF-containing space of a subject using a filtration system;

filtering the volume of fluid into permeate and retentate using a first filter of the filtration system, wherein the first filter comprises a tangential flow filter;

returning the permeate to the CSF-containing space of the subject;

filtering the retentate into a filtered retenate and a second retenate using a second filter of the filtration system;

returning the filtered retentate to the CSF-containing space of the subject; and

calculating a waste rate of the filtration system and modifying one or more parameters of the system that influence the waste rate to maintain the waste rate less than a threshold, wherein the threshold is 0.25 milliliters of CSF per minute.

2. The method of claim 1 , wherein the second filter of the filtration system comprises a dead end filter or a depth filter.

3. The method of claim 1 , further comprising:

prior to returning the permeate and prior to returning the filtered retentate, combining the permeate and the filtered retentate at a combiner; and

returning the combined permeate and the filtered retentate to the CSF-containing space of the subject, thereby returning the permeate and returning the filtered retentate.

4. The method of claim 3 , wherein the combiner includes a check-valve configured to resist back flow into the second filter.

5. The method of claim 1 , wherein the threshold is based on a predicted rate of natural CSF production in the subject.

6. The method of claim 1 , wherein the threshold is 0.20 milliliters of CSF per minute.

7. The method of claim 1 , wherein the second filter of the filtration system comprises a tangential flow filter configured to filter the retentate into a second permeate and the second retentate;

wherein returning the filtered retentate to the CSF-containing space of the subject comprises returning the second permeate to the CSF-containing space of the subject; and

wherein the method further comprises:

filtering the second retentate using a third filter of the filtration system into a fluid passing through the third filter, and a third retenate; and

returning the fluid passing through the third filter to the CSF-containing space of the subject.

8. The method of claim 1 , wherein the one or more parameters include flow rate, pressure, rate of addition of artificial CSF, filtration parameters, or combinations thereof.

9. A method for filtering materials from cerebrospinal fluid (CSF) of a human or animal subject, the method comprising:

withdrawing a volume of fluid comprising CSF from a CSF-containing space of a subject using a filtration system;

filtering the volume of fluid into permeate and retentate using a first filter of the filtration system, wherein the first filter comprises a tangential flow filter;

filtering the retentate into a filtered retenate and a second retenate using a plurality of second filters of the filtration system operating in parallel;

combining the permeate and the filtered retentate at a combiner;

returning the combined permeate and the filtered retentate to the CSF-containing space of the subject, and

calculating a waste rate of the filtration system and modifying one or more parameters of the system that influence the waste rate to maintain the waste rate less than a threshold, wherein the threshold is 0.25 milliliters of CSF per minute.

10. The method of claim 9 , wherein the plurality of second filters comprise one or more dead end filters or depth filters.

11. The method of claim 9 , wherein the combiner includes a check-valve configured to prevent back flow into the plurality of second filters.

12. The method of claim 9 , wherein the threshold is 0.20 milliliters of CSF per minute.

13. A system for filtering materials from cerebrospinal fluid (CSF) of a human or animal subject, the system comprising:

a first filter comprising a tangential flow filter configured to filter a volume of CSF into permeate and retentate, the first filter having a permeate outlet for the permeate and a retentate outlet for the retentate;

a second filter having an intake and an outlet, the intake coupled to the retentate outlet;

a combiner coupled to the permeate outlet and the outlet of the second filter, the combiner is configured to combine the fluid filtered by the second filter and the permeate from the first filter, wherein the combiner has an outlet for returning fluid to a CSF-containing space of the subject, and

a processing unit for calculating a waste rate of the filtration system and modifying one or more parameters of the system that influence the waste rate to maintain the waste rate less than a threshold of 0.25 milliliters of CSF per minute.

14. The system of claim 13 , wherein the second filter comprises a dead end or depth filter.

15. The system of claim 13 , wherein the combiner includes a check-valve configured to prevent back flow into the second filter.

16. The system of claim 13 , wherein the second filter comprises a tangential flow filter configured to filter the retentate from the first filter into a second permeate and a second retentate, the second filter having a second permeate outlet for the second permeate and a second retentate outlet for the second retentate;

wherein the system further comprises a third filter having an intake coupled to the second retentate outlet; and

wherein the combiner is coupled to the permeate outlet, the second permeate outlet, and an outlet of the third filter, and configured to combine the permeate, the second permeate, and the fluid filtered by the third filter.

17. The system of claim 13 , wherein the second filter comprises a plurality of dead end or depth filters arranged in parallel.

18. The system of claim 17 , wherein the plurality of dead end filters or depth filters in parallel are self-regulating, such that as one of the dead end filters or depth filters becomes full, or clogged, pressure increases, resulting in more waste fluid being directed to one or more other dead end filters or depth filters.

19. A method for filtering materials from cerebrospinal fluid (CSF) of a human or animal subject, the method comprising:

withdrawing a volume of fluid comprising CSF from a CSF-containing space of a subject using a filtration system;

filtering the volume of fluid into permeate and retentate using a first filter of the filtration system, wherein the first filter comprises a tangential flow filter;

returning the permeate to the CSF-containing space of the subject;

filtering the retentate into a filtered retenate and a second retenate using a second filter of the filtration system;

returning the filtered retentate to the CSF-containing space of the subject; and

maintaining a waste rate of the filtration system of less than a threshold of 0.25 milliliters of CSF per minute.

20. A method for filtering materials from cerebrospinal fluid (CSF) of a human or animal subject, the method comprising:

withdrawing a volume of fluid comprising CSF from a CSF-containing space of a subject using a filtration system;

filtering the volume of fluid into permeate and retentate using a first filter of the filtration system, wherein the first filter comprises a tangential flow filter;

filtering the retentate into a filtered retenate and a second retenate using a plurality of second filters of the filtration system operating in parallel;

combining the permeate and the filtered retentate at a combiner;

returning the combined permeate and the filtered retentate to the CSF-containing space of the subject; and

maintaining a waste rate of the filtration system of less than a threshold of 0.20 milliliters of CSF per minute.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2025
From: MINNETRONIX NEURO, INC.
To: PHARAOH NEURO, INC.
Reel/Frame 073429/0607 →
RELEASE OF PATENT SECURITY AGREEMENT - REEL/FRAME 054795/0607, SUPPLEMENTAL PATENT SECURITY AGREEMENT - REAL/FRAME 056240/0147 AND ASSIGNMENT ID: 885388 Recorded Oct 1, 2025
From: TEXAS CAPITAL BANK, AS AGENT
To: MINNETRONIX MEDICAL, INC.
Reel/Frame 073434/0838 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2025
From: MINNETRONIX, INC.
To: MINNETRONIX NEURO, INC.
Reel/Frame 071588/0980 →
PARTIAL RELEASE OF PATENT SECURITY AGREEMENT - REEL 054795 FRAME 0607; AND REEL 056240 FRAME 0147 Recorded Jun 10, 2025
From: TEXAS CAPITAL BANK, AS ADMINISTRATIVE AGENT
To: MINNETRONIX, INC.; MINNETRONIX NEURO, INC. (F/K/A NEUROFLUIDICS, INC.)
Reel/Frame 071588/0015 →
ASSIGNMENT OF SECURITY INTEREST IN PATENT COLLATERAL RECORDED ON REEL 054795 FRAME 0607 AND SUPPLEMENTAL PATENT SECURITY AGREEMENT RECORDED ON REEL 056240 FRAME 0147 Recorded Mar 13, 2025
From: FIRST HORIZON BANK
To: TEXAS CAPITAL BANK, AS SUCCESSOR AGENT
Reel/Frame 073460/0969 →
SECURITY INTEREST Recorded Jan 4, 2021
From: MINNETRONIX MEDICAL, INC.; MINNETRONIX NEURO, INC.
To: FIRST HORIZON BANK, AS ADMINISTRATIVE AGENT
Reel/Frame 054795/0607 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2017
From: MEYERING, EMILY ROLFES; SEIM, GARY; VASE, ABHI; KREHBIEL, BEN; HEDSTROM, BLAKE; MCCABE, AARON; MONDRY, JACK
To: MINNETRONIX, INC.
Reel/Frame 044034/0937 →
Continuity (2)
Provisional Application 62201287 · Aug 5, 2015
Related Publication 20170035950A1 · Feb 9, 2017
Cited By (2)
US 12,290,785 US 12,364,952